Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...
And, as it turns out, fiber is pretty essential for your overall health—supporting everything from your digestion to your microbiome, yet most of us aren’t getting nearly enou ...
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
About half of U.S. adults have high blood pressure and too few have it under control. Now some patients who've tried ...
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...
21h
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated ...
Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback